Joseph M. Miller

Chief Financial Officer, LB Pharmaceuticals Inc

In the seat. First published here October 28, 2026; built from records as of October 28, 2026.

Joseph M. Miller has been Chief Financial Officer of LB Pharmaceuticals Inc since September 2, 2026, according to the company's filing of September 3, 2026.¹

The filing gives Joseph M. Miller's previous role as Chief Financial Officer at Aurinia Pharmaceuticals Inc.¹ Joseph M. Miller joined from outside LB Pharmaceuticals Inc, by the record's reading of the filing.¹ The filing shows an earlier chief financial officer seat, so this is not Joseph M. Miller's first.¹

Seats

The seat in the record

Company	Title as filed	Standing	Filings
LB Pharmaceuticals Inc (LBRX) Pharmaceutical Preparations	Chief Financial Officer	In the seat	1

Company names link to the company's page in the record at CFO Tribune, which holds the seat history.

The record

Filing by filing, latest first

September 2, 2026effective
LB Pharmaceuticals Inc appointed Joseph M. Miller as Chief Financial Officer, effective September 2, 2026.
Miller has been appointed to serve as the Company’s Chief Financial Officer, effective as of September 2, 2026 (the “Start Date”).
[1] Filing by LB Pharmaceuticals Inc, filed with the SEC on September 3, 2026. Read the filing. The record at CFO Tribune.

Sources

Current report filed with the SEC, LB Pharmaceuticals Inc. U.S. Securities and Exchange Commission, EDGAR, filed September 3, 2026. sec.gov; record.

Corrections and removal

If a line here is wrong, or Joseph M. Miller wants this profile taken down, write to corrections@cfospotlights.com. Corrections are made on the page with a dated note; removal requests are answered within 72 hours. The underlying filings stay public at the SEC.